A purple and pink letter v on a white background.
August 22, 2014

Why the Venus Concept Business Model Is a Power Player

Decades of experience and business savvy are ideal characteristics for any potential partner you would want to collaborate with. Particularly for physicians, who have to make large capital investments in their practices, having a power player like Venus Concept to support your clinic amplifies your ROI.

Venus Concept has been leading the way with its innovative treatments and practice management tools, delivering benefits from the company’s insight of what works – and what can work better in the future.

Dr. Michael Gold of The Gold Skincare Center in Tennessee counts the Venus Legacy system as one of the leading, most-profitable machines in his clinic. “I judge a machine and the treatments on how the patient responds. I have over 45 energy-based devices in my clinic, “ he says. Based on his experience, the Venus Legacy operates from open-to-close to fulfill the demand patients have for it.

“If you have a good experience, you’re going to tell your friends,” he says. “We don’t have to do a lot of advertising, it sells itself.”

Perhaps what is most exciting is that the Venus Legacy addresses the three key factors that Dr. Gold and other physicians seek in non-invasive treatments:

“A. It works. B. The patient satisfaction is really high. C. The side effect profile is minimal,” explains Dr. Gold. Venus Legacy is ultimately “safe, painless, a minimally invasive treatment that gives us the results we’re looking for.”

The Venus Legacy, for example, is praised for its ability to deliver maximum energy while maintaining a comfortable patient experience – combating cellulite and working wonders on body contouring. “If you do a treatment that hurts, and it’s the best thing in the world, but it’s so painful – they’re not going to tell their friends, and they’re not going to come back if they need more treatments,” explains Dr. Gold of how critical it is to have a safe, painless yet powerfully effective treatment for patients.

As President and CEO of Venus Concept, Domenic Serafino has been in theindustry for 22 years. He echoes Dr. Gold’s take on doctors and clinics benefitting from Venus Concept’s extensive support and capabilities.

“Physicians are science-based people, they’re not business-oriented people. For those who are able to provide a solution that’s not only a technology but also a solution of how to bring patients to the clinic, how to manage those patients, how to help your staff be efficient within your clinic – that’s the most important thing a company can do today,” he says.

Mr. Serafino goes on to explain how this business model works for Venus Concept:

“We’re prepared to put our money where our mouth is, so we aligned ourselves with physicians essentially building a subscription-based business which offers doctors cash flow so they don’t tie up their personal cash they need for running their practise by using our technologies. Consequently we provide them enough support to ensure that they’re successful.”

If you consider that clinics may have to replace machines upwards of $100,000 in value every 18 months, having access to Venus Concept’s subscription-based solution can be a great way to get the ball rolling. Additionally, Venus Concept offers extra support including anything from marketing consultation to social media strategy.

“Doctors are working with a company that says ‘Ok, what do you need to learn, Doctor X?’” says Dr. Gold of The Gold Skincare Center. Perhaps it is social media support, or knowing how to get on Facebook or properly leverage Instagram. “ These are tools  most of us don’t use,” he admits.

This ability to get Venus Concept’s guidance and support to reach prospects and build clients is what separates the company according to Dr. Gold. “We have a business model that works.”

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.